Boehringer Ingelheim’s Strategic Move in Pet Health
Boehringer Ingelheim acquires Saiba Animal Health, boosting pet R&D with innovative therapeutic vaccines.
- Latest
- Trending
Boehringer Ingelheim acquires Saiba Animal Health, boosting pet R&D with innovative therapeutic vaccines.
AI tools like those from GE and AWS aim to revolutionize healthcare by unlocking vast amounts of underutilized medical data.
A purring cat can alleviate stress, offering a glimpse of a world with optimal stress management, fostering harmony and reducing ...
The number of 401(k) millionaires is on the rise and average account balances are the highest in two years due ...
As lifespans increase and demographics shift, retirement is being redefined. Companies must adapt to meet the needs of an aging ...
Inherited IRAs are an important part of estate planning, but there are specific rules and tax implications to consider. Beneficiaries ...
Retirement income strategies are crucial to ensure a comfortable and secure future. Finding the balance between withdrawals and longevity risk ...
Americans aged 55+ owning 80% of US stocks poses a downside risk, especially during a recession. Demographic-induced selling could impact ...
The potential of AI in revolutionizing disease prevention and management and the challenges it faces in the healthcare system.
Mynd Immersive launches the Great American Elderverse at CES 2024, aiming to revolutionize senior care and combat loneliness with VR ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.